Xena and 2014, as I stated (post #48179) IMO the shorts aren't done with AVXL and might believe there is one last chance to strike hard at it, which will be when the 12 week data is released. Their guns are loaded and will be out in force at that time.
I don't believe they have given up trying to suck the wind out of AVXL's sails and kill its momentum before NIH money comes to fruition or a new study based on FDA guidance is announced. If the shorts can create enough doubt within shareholders and outside support groups, then they might win.
Remember that a weak hit piece caused the SP to go from a high of $8.03 on 12/15 to $4.60 on the 31st, a loss of 42%+, so there are still weak hands in the s/holder group, regardless of what is professed here.
As an aside ... Xena, considering your dagger's mantra, "In Peace, In War," I would think you'd be prepared for the later.
News 
Market Data 
Discover 
